The main body of text in the manuscript summarizes and discusses the most important results 10 of the study. This supplementary file provides further details on the simulation modeling 11 methodology that was used, the process map underlying the simulation model, model data, 12 and input parameters characterizing scenarios studied. 13 14 Simulation modeling methodology 15 Monte Carlo simulation 16 The simulation model built conforms to the notion of Monte Carlo simulation. 1, 2 The model 17 represents the acute stroke pathway as it evolves over time by a representation in which state 18 variables change instantaneously at separate, i.e. discrete, points in time. 3 Variety in patient 19 characteristics, activity durations, and medical decision making concerning diagnosis, and 20 intravenous thrombolysis (IVT) treatment are incorporated into the model by probability 21 distributions derived from real system (patient) data. Activity durations include possible 22 patient queueing times, if any, as the stroke patients' urgency usually allows them to queue 23 Supplementary material BMJ Open
Introduction
Model -process map and data 1 Model set-up conforms to description of the stroke pathway (Main text, Figure 1 ). Further 2 details are provided in the process map ( Figure S1 ) and the overview of distributions of time 3 delays and diagnostic characteristics (Table S1 ). All time delays are expressed in minutes. 4 Patients are classified according to their route, i.e., mode of transportation towards the 5 hospital: 6 (1) Emergency Medical Services (EMS): Assumes patients being transported to the hospital 7 by EMS. A patient can be in Route 1 with a probability of 76%. If the patient is in Route 1, 8 then the following quantities need to be simulated for modelling pre-hospital activities: the 9 time from symptom onset to call for help, the choice and time delay at the first responder (i.e. 10 either the general practitioner or 911), the level of urgency set for EMS transport, the time 11 between 911 activation and arrival of the ambulance at the location of the patient, the time 12 spent by ambulance personnel at the location of the patient, and the time required to transport 13 the patient to the hospital. Three levels of urgency for EMS transport are distinguished, i.e., to laboratory examination of patient blood samples, the time to reach a decision on patient 20 treatment, and the time it takes to mix thrombolytics.
21
A small group of patients (2% of overall population) in route 1 is initially transported to a 22 community hospital offering no stroke services, thereby facing significant time losses. As The efficacy of intravenous tissue plasminogen activator in acute brain infarction is greater 2 the earlier it is administered, and the clinical benefit declines progressively over 4.5 hours 3 after stroke onset. 8 For the simulation model the likelihood of treatment is approximated by a 4 linear function, see Figure S2 . We used a linear regression model (Y-axis intercept 97.5; slope 5 -0.33) to approximate the chance of IVT treatment set against the overall process time for all 6 patients arriving < 4.5 hours from the onset of stroke symptoms (i.e. eligible for IVT 7 treatment). 34 (16) 4 (2) 8 (4) 13 (6) 15 (7) 13 (6) 19 (9) 13 (6) 9 (4) 12 (6) 73 (34) Scenario 1A,B,C (patient responsiveness): Distribution parameters are adjusted by a factor equal to the quotient of the respective median response times reported for best practices, i.e., 30 (1A), 15 (1B), and 0 minutes (1C), and the baseline scenario (41 minutes). Figure S2 . Treatment decision: a patient's chance of being treated given the overall process time.
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